Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - Co-Founder, President, CEO & Director Zachary Roberts - EVP, Research & Development Eric Schmidt - CFO Conference Call Participants Jenna Li - Jefferies Tyler Van Buren - Cowen and Company Brian Cheng - JPMorgan Chase & Co. Charles Butler - EF Hutton John Newman - Canaccord Genuity David Dai - SMBC Mark Breidenbach - Oppe ...